NEW YORK, Nov. 23, 2018 /PRNewswire/ — Embargoed: 3am EST, Thursday 22 November 2018 World-renowned cartographer of the brain, Scientia Professor George Paxinos AO, from Continue Reading
admin
Editorial administrator
Fitbit launches the new Charge 3 in time for the Holiday Season
HONG KONG, Nov. 23, 2018 /PRNewswire/ — Fitbit has launched the new Charge 3 in time for the holiday season. Fitbit is the industry-leader in Continue Reading
Focusing on the Advanced Productivity in the Pharmaceutical Field, P-MEC China 2019 Arrives in Shanghai
SHANGHAI, Nov. 22, 2018 /PRNewswire/ — As an extension of P-MEC brand and a world famous pharmaceutical machinery exhibition in China, P-MEC China hosted by Continue Reading
KT Partners with Ghana Gov’t for Epidemic Preparedness
KT Signs Agreement with Ghana Health Service for Disease Prevention Korean Telecom Leader Brings Technology to Help People Around World SEOUL, South Korea, Nov. 22, Continue Reading
Fully resorbable synthetic matrix offers improved safety for breast cancer patients undergoing immediate breast reconstruction
UPPSALA, Sweden, Nov. 21, 2018 /PRNewswire/ — Using the synthetic and fully resorbable TIGR®Matrix surgical mesh (Novus Scientific AB, Uppsala — Sweden) improves the outcome in Continue Reading
Ping An Group Appoints International General Counsel
HONG KONG, Nov. 21, 2018 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”) (HKEx: 2318; SSE: 601318) Continue Reading
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million
SYDNEY, Nov. 20, 2018 /PRNewswire/ — Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the Share Continue Reading
Festive Nostalgia Leaves No Scone Unturned
MELBOURNE, Australia, Nov. 20, 2018 /PRNewswire/ — Chestnuts roasting on an open fire and fresh pumpkin pie are synonymous with cherished childhood memories of the Continue Reading
Mundipharma Signs Major Agreement with Kolon Life Sciences to Bring World’s First Gene Therapy for Knee Osteoarthritis to Japan
Multi-year Invossa® deal signed for up to USD 600 million Mundipharma will be responsible for the development, marketing and distribution of Invossa® to medical professionals Continue Reading
CStone initiates a bridging Phase I clinical trial for PD-1 antibody CS1003 with first patient dosed in China
SUZHOU, China, Nov. 19, 2018 /PRNewswire/ — CStone Pharmaceuticals (CStone) today announced that a first patient has been enrolled and dosed in a Phase I clinical Continue Reading